ACCRETION PHARMACE...● IPO DETAIL GMPNIL STATUSListed IPOCloudTrack Every IPO ACCRETION PHARMACE...● IPO DETAIL GMPNIL STATUSListed IPOCloudTrack Every IPO
Live GMP
Back to IPOs
Accretion Pharmaceuticals Ltd

Accretion Pharmaceuticals Ltd

NSE SME · SME IPO
Listed NSE SME SME Live Chart
Issue Price
₹101
₹101
GMP (Grey Market)
NIL
Unofficial data only
Est. Listing Price
₹101
Based on GMP
Min. Investment
₹121,200
1 lot × 1200 shares
Subscribed
1.00x
Over-subscribed
IPO Details
Open Date
14 May 2025
Close Date
16 May 2025
Allotment
19 May 2025
Listing Date
21 May 2025
Exchange
NSE SME
Price Band
₹101
Listing Price
See chart
Allotment Status
Price Band
₹101
Per share
Face Value
₹10 per share
 
Lot Size
1,200 Shares
per lot
Issue Size
29,46,000 shares (aggregating up to ₹29.75 Cr)
Total offering
Issue Type
Bookbuilding IPO
 
Min Investment
₹121,200
1 lot
Pre-IPO Holding
81,70,000 shares
Promoters
Post-IPO Holding
1,11,16,000 shares
Promoters
P/E (Pre)
21.29x
 
P/E (Post)
16.08x
 
EPS (Pre)
₹4.74
 
EPS (Post)
₹6.28
 
UPI Deadline
5:00 PM on 16 May 2025
Mandate
Anchor AllotmentTue, 13 May 2025
Basis of AllotmentMon, 19 May 2025
Refund InitiationTue, 20 May 2025
Demat CreditMon, 19 May 2025
Listing DayWed, 21 May 2025
UPI Mandate Deadline5:00 PM on 16 May 2025
Sale TypeFresh Capital
Net Offer to Public27,98,400 shares (aggregating up to ₹28.26 Cr)
Market Maker Quota1,47,600 shares (aggregating up to ₹1.49 Cr)
QIB Quota50% of Net Issue
HNI / NII Quota15% of Net Issue
Retail Quota35% of Net Issue
Check AllotmentClick here →
Subscription Rate Final
Accretion Pharmaceuticals Ltd IPO subscribed 1.00 times overall. Retail: 1.00x. QIB: 1.00x. NII: 1.00x. By 16 May 2025.
QIB
1.00x
Over
NII/HNI
1.00x
Over
Retail
1.00x
Over
Total
1.00x
Over
Category Subscription Shares Offered % of Total Amount (₹Cr)
Market Maker
Awaited
147,600
₹1.49
QIB
Over 1.00x
NII / HNI
Over 1.00x
Retail
Over 1.00x
Total 1.00x
2,946,000
100% ₹29.75
IPO Shares Offered
Accretion Pharmaceuticals Ltd IPO total issue size: ₹29.75 Cr.
CategoryShares OfferedAmount (₹Cr)Size (%)
Market Maker 147,600 ₹1.49
5.01%
Total 2,946,000 ₹29.75
100.00%
* Based on upper price band ₹101 per share
Lot Size & Investment
Lot Size
1,200
Shares per Lot
Issue Price
₹101.00
Upper Band
Min Investment
₹121,200
1 Lot
ApplicationLotsSharesAmount
Retail (Min — 2 Lots)22,400₹242,400
Retail (Max — 13 Lots)1315,600₹1,575,600
S-HNI (Min — 14 Lots)1416,800₹1,696,800
B-HNI (Min — 68 Lots)6881,600₹8,241,600
* Issue Price ₹101 × Lot Size 1,200 shares
IPO Schedule
Anchor
13 May 2025
✓ Done
IPO Open
14 May 2025
✓ Done
IPO Close
16 May 2025
✓ Done
Allotment
19 May 2025
✓ Done
Refunds
20 May 2025
✓ Done
Demat Credit
19 May 2025
✓ Done
Listing Day
21 May 2025
✓ Done
Accretion Pharmaceuticals Ltd — Live Price LIVE
₹101.00
INR · NSE
Fetching…
vs Issue Price
OPEN
HIGH
LOW
MKT CAP
P/E
52W HIGH
52W LOW
VOLUME
DIVIDEND
DIV YIELD
Loading…
Chart Not Available
Try again 2–3 days after listing.
Issue ₹101.00 Live Price
About Accretion Pharmaceuticals Ltd
Incorporated in 2012, Accretion Pharmaceuticals Limited is a pharmaceutical company that manufactures and sells tablets, capsules, and other healthcare products.The company also offers contract manufacturing services. The Company manufactures and markets Tablets, Capsules, Oral Liquids, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), and Oral Powder (Sachet, Dry Syrup).The company also holds ISO 9001:2015, ISO 14001:2015, and ISO 22000:2005 certifications, reflecting its dedication to quality and environmental management systems.The company's manufacturing unit is located in Ahmedabad, Sanand, Gujarat.The company has expanded its global footprint, marking its presence in more than 20 countries, including regions in Africa, Southeast Asia, and the Middle East.Product Portfolio and ServicesTablets and Capsules – Covering antibiotics, anti-inflammatory, pain management, cardiovascular, and gastrointestinal medicines.Oral Liquids and Syrups – Used for respiratory, pediatric, and digestive treatments.External Preparations – Including medicated lotions, gels, ointments, and dusting powders for skin care and dermatological treatments.Ayurvedic and Herbal Products – Focused on natural wellness solutions for immunity, digestion, and general health.As of January 2025, the company has 83 employees (including 4 Executive Directors) on its payroll.Competitive Strength:Experienced Promoters and Management Team.Long-standing relationship with clients and suppliers.Focus on providing quality products.Management has built a supply chain and customer relations, creating goodwill and trust.
Objects of the Issue
1
Capital expenditure towards purchase of new equipment/ machineries, etc.
2
Capital expenditure towards upgradation of existing manufacturing facility
3
Repayment/prepayme nt of certain borrowings availed by the Company
4
Funding working capital requirements
5
General Corporate Purpose
Accretion Pharmaceuticals Ltd Financials (Amount in ₹ Crore)
Revenue from Operations
₹29.5
31 Mar 2023
₹33.9
31 Mar 2024
₹35.8
31 Dec 2024
Profit After Tax (PAT)
₹0.1
31 Mar 2023
₹3.9
31 Mar 2024
₹5.2
31 Dec 2024
Particulars31 Dec 202431 Mar 202431 Mar 2023
Revenue from Operations 35.75 33.94 29.53
EBITDA N/A N/A N/A
Profit After Tax (PAT) 5.24 3.88 0.10
Net Worth 13.58 5.35 3.84
Total Assets 39.99 27.05 20.58
Reserves & Surplus 5.41 1.35 0.00
Borrowings 13.79 13.48 8.47
EBITDA Margin (%) N/A
PAT Margin (%) 11.51%
P/BV Ratio
7.55
RoE
72.47%
RoCE
36.73%
RoNW
72.47%
PAT Margin
11.51%
Debt/Equity
2.52
Issue Structure & Shareholding
Total Shares Offered29,46,000 (100.00%)
Net Offer to Public27,98,400 shares (aggregating up to ₹28.26 Cr)
Reserved for Market Maker1,47,600 shares (aggregating up to ₹1.49 Cr)
Pre-Issue Promoter Holding81,70,000 shares
Post-Issue Promoter Holding1,11,16,000 shares
P/BV Ratio7.55
RoE72.47%
RoCE36.73%
Debt / Equity2.52
Script CodeN/A
Registrar & Lead Managers
Book Running Lead Managers
Jawa Capital Services Pvt.Ltd
GMP Disclaimer: Grey Market Premium data is unofficial and unregulated. It does not guarantee actual listing price.
IPO Subscription FAQs
How much Accretion Pharmaceuticals Ltd IPO subscribed?

Accretion Pharmaceuticals Ltd IPO is subscribed 1.00 times by May 16, 2025. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.

Investor CategorySubscription
Qualified Institutional (QIB)1.00x
Non Institutional (NII/HNI)1.00x
Retail Individual1.00x
Total Subscription1.00x
What is Accretion Pharmaceuticals Ltd IPO retail subscription status?

The Accretion Pharmaceuticals Ltd IPO retail category is subscribed 1.00 times as of 16 May 2025. The retail portion is oversubscribed.

How to subscribe Accretion Pharmaceuticals Ltd IPO?

Subscribe via your broker app using ASBA or UPI. Opens 14 May 2025 and closes 16 May 2025. Min investment: ₹121,200 (1 lot = 1,200 shares). UPI mandate: 5:00 PM on 16 May 2025.

How many times Accretion Pharmaceuticals Ltd IPO subscribed?

The Accretion Pharmaceuticals Ltd IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.

How to check Accretion Pharmaceuticals Ltd IPO allotment?

Check allotment on the registrar website (Kfin Technologies Ltd) at https://ipostatus.kfintech.com/. Enter your PAN, application number or DP/Client ID. Allotment date: 19 May 2025. Refunds: on 20 May 2025.

When Accretion Pharmaceuticals Ltd IPO will be listed?

The Accretion Pharmaceuticals Ltd IPO listing date is 21 May 2025, Wednesday. Listed on: NSE SME. Issue price: ₹101. Estimated listing: ₹101. GMP: NIL.

When Accretion Pharmaceuticals Ltd IPO close?

The Accretion Pharmaceuticals Ltd IPO closes on 16 May 2025, Friday. UPI mandate: 5:00 PM on 16 May 2025. Allotment: 19 May 2025. Listing: 21 May 2025.